The path to personalised medicine in COPD
- Correspondence to Dr Alvar Agustí, Institut del Tòrax, Hospital Clínic, IDIBAPS, Universitat de Barcelona and CIBER Enfermedades Respiratorias, Villarroel 170, Escala 3, Planta 5, Barcelona 08036, Spain;
- Received 2 April 2014
- Accepted 3 April 2014
- Published Online First 29 April 2014
Our understanding of chronic obstructive pulmonary disease (COPD) has changed dramatically over the past two decades. We have moved from an airflow limitation-centric view to the realisation that COPD is a complex and heterogeneous disease, which leads inevitably to the need for personalising the assessment and treatment of patients with COPD. This review provides a brief perspective of the extraordinary transition that the COPD field has experienced in the last two decades, and speculates on how it should/can move forward in the near future in order to really achieve the goal of personalising COPD medicine in the clinic.